Reviva Pharmaceuticals Holdings, Inc. (RVPH) stock
RVPHOTCPharmaceutical PreparationsFiscal year ends December 31
$0.45−0.02 (-4.36%)
Close on Oct 19, 2026Market cap $5.94MP/E –Yield –
Reviva Pharmaceuticals price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
No price to sales ratio figures for Reviva Pharmaceuticals
Reviva Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?